Skip to main content

CSM Advisors, LLC

SEC CIK
0001863523
Latest filing
Aug 14, 2026

ABT holding history

Abbott Laboratories in every 13F filed by CSM Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
12,943
Value
$1.17M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by CSM Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202612,943$1.17M<0.1%−1,114−7.9%ReducedHolders
Q1 202614,057$1.44M<0.1%−589−4.0%ReducedHolders
Q4 202514,646$1.83M<0.1%−17,035−53.8%ReducedHolders
Q3 202531,681$4.24M0.1%−65,130−67.3%ReducedHolders
Q2 202596,811$13.2M0.4%+1,090+1.1%AddedHolders
Q1 202595,721$12.7M0.7%−2,280−2.3%ReducedHolders
Q4 202498,001$11.1M0.5%−2,595−2.6%ReducedHolders
Q3 2024100,596$11.5M0.7%−5,086−4.8%ReducedHolders
Q2 2024105,682$11.0M0.8%−2,130−2.0%ReducedHolders
Q1 2024107,812$12.3M0.8%−1,520−1.4%ReducedHolders
Q4 2023109,332$12.0M0.9%−892−0.8%ReducedHolders
Q3 2023110,224$10.7M0.9%−1,090−1.0%ReducedHolders
Q2 2023111,314$12.1M0.9%−5,415−4.6%ReducedHolders
Q1 2023116,729$11.8M1.0%+7,850+7.2%AddedHolders
Q4 2022108,879$12.0M1.1%+2,480+2.3%AddedHolders
Q3 2022106,399$10.3M1.1%−8,610−7.5%ReducedHolders
Q2 2022115,009$12.5M1.2%−860−0.7%ReducedHolders
Q1 2022115,869$13.7M1.0%−18,090−13.5%ReducedHolders
Q4 2021133,959$18.9M1.3%−815−0.6%ReducedHolders
Q3 2021134,774$15.9M1.2%+600.0%AddedHolders
Q2 2021134,714$15.6M1.0%−8,859−6.2%ReducedHolders
Q1 2021143,573$17.2M2.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.